![Alex Trebeks Cbd Gummies: A Practical Look At The Celebrity Linked Trend [zydRGYwbdTp]](https://cedclinic.com/wp-content/uploads/2026/06/ced-pexels-5469158-150x150.jpg "Alex Trebeks Cbd Gummies: A Practical Look At The Celebrity Linked Trend [zydRGYwbdTp] 9")
Cannabis Reduces Tics in Tourette Syndrome: 306 Patients
Dr. Benjamin Caplan, MD | Board-Certified Family Physician & Cannabis Medicine Specialist | Cannabis Science | June 5, 2026 Clinical Insight A meta-analysis of eight clinical studies and 306 adult patients found that cannabis-based medicines produced…
CBD for Severe Autism: What a 27-Month Study Found
A new long-term observational study published in Pharmacology Biochemistry and Behavior followed children with severe autism spectrum disorder on purified CBD for an average of 27.6 months. Improvements seen at three months were maintained, and 40% of…
FDA Grants Cannabis Extract VER-01 Breakthrough Therapy Status for Pain
The FDA has awarded Breakthrough Therapy Designation to VER-01, a pharmaceutical-grade cannabis extract for chronic low back pain. This marks the first FDA breakthrough therapy cannabis designation for pain treatment, backed by Phase 3 trials showing…
What a Large 2026 Study Reveals About GLP-1 Medications and Hair Loss
Semaglutide hair loss risk emerged as a significant signal in a large propensity-matched cohort study involving hundreds of thousands of patients. Researchers found higher rates of nonscarring hair loss among semaglutide and tirzepatide users compared…
GLP-1 Drugs, Semaglutide, and the Future of Alcohol Addiction Treatment
GLP-1 receptor agonists for alcohol use disorder are attracting growing scientific interest as potential tools for reducing alcohol consumption and relapse risk. This review examines preclinical evidence, observational studies, and randomized controlled…
Weight Loss Outcomes Between GLP-1 Receptor Agonists and Bariatric Surgery in Adults
GLP-1 bariatric surgery meta-analysis evidence suggests bariatric surgery produced greater long-term weight and BMI reduction in the reviewed studies. The comparison also found stronger longer-term glycemic outcomes for surgery, while lipid and blood…
Weight Loss, Metabolic Health, and Psychiatric Safety
Semaglutide for schizophrenia weight gain is emerging as a focused metabolic strategy for patients whose antipsychotic treatment has created serious weight and glucose burden. This Evidence Watch review examines RCT meta-analysis data showing meaningful…
Use of Oral Semaglutide and Associated Clinical Outcomes in Thai Patients With Diabetes
The REALISED study shows significant improvements in HbA1c and body weight among Thai patients using oral semaglutide. No severe hypoglycaemia was reported.
Superior Cerebrovascular Outcomes with Tirzepatide versus Semaglutide in Diabetic Patients
A study comparing Tirzepatide to Semaglutide in diabetic CABG patients found significant benefits for cerebrovascular and cardiovascular outcomes, reducing mortality and complications.
Systematic Characterisation of GLP-1R in Human Enteric Nervous System- Implicati
GLP-1R is abundantly expressed in the colonic enteric nervous system, preferentially in inhibitory neurons. This study provides insights into GLP-1 receptor agonist-induced gastrointestinal dysmotility.